CITADEL ADVISORS LLC

Position in INM — InMed Pharmaceuticals Inc.

CIK 1423053 MIAMI, FL

Position in INM

as of Jun 30, 2026 · filed Sep 2, 2026 Compact

Position Value

$40,430

+$10,133 QoQ

Shares Held

26,084

-44.5% QoQ

Ownership

0.475%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 20 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,824 across 65 Drug Manufacturers - Specialty & Generic names. INM ranks #58 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	9,668,611	$237,944,516
2	ZTS	Zoetis Inc.	3,188,263	$229,108,578
3	UTHR	UNITED THERAPEUTICS Corp	304,692	$165,091,266
4	LNTH	Lantheus Holdings, Inc.	1,376,480	$152,706,691
5	INDV	Indivior Pharmaceuticals, Inc.	2,667,827	$109,460,941
6	ALKS	Alkermes plc.	1,645,101	$86,203,291
7	SUPN	Supernus Pharmaceuticals, Inc.	1,373,982	$63,903,902
8	HIMS	Hims & Hers Health, Inc.	846,936	$29,363,271

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,430	26,084	-44.5%	Shares	Defined	2026-09-02
2026-03-31	$30,297	46,973	-17.1%	Shares	Defined	2026-05-15
2024-09-30	$13,429	56,666	+368.4%	Shares	Defined	2024-11-14
2024-06-30	$3,217	12,097	-4.9%	Shares	Defined	2024-08-14
2024-03-31	$4,631	12,725	-62.6%	Shares	Defined	2024-05-15
2023-12-31	$14,147	34,009	+162.3%	Shares	Defined	2024-02-14
2022-06-30	$6,094	12,966	+17.2%	Shares	Defined	2022-08-15
2021-12-31	$14,488	11,060	-38.4%	Shares	Defined	2022-02-14
2021-09-30	$31,398	17,942	+17.2%	Shares	Defined	2021-11-15
2021-06-30	$48,685	15,310	-11.0%	Shares	Defined	2021-08-16
2021-03-31	$56,796	17,211	—	Shares	Defined	2021-05-21
No filing history on record for this holder in this stock.